Table II. Performance of 28 IgA biomarkers in Phase I.

Gene symbol	Sensitivity	Specificity	Discriminative ability	Rank
SS18	30.4%	96.4%	63.4%	1
YP021	27.5%	96.4%	61.9%	2
APH1A	27.5%	96.4%	61.9%	3
TOM1L2	27.5%	96.4%	61.9%	4
PIP4K2C	26.1%	94.5%	60.3%	5
NUMBL	29.0%	90.9%	59.9%	6
NUDT14	23.2%	96.4%	59.8%	7
RALGDS	24.6%	94.5%	59.6%	8
SPN	18.8%	100.0%	59.4%	9
RPLP1	24.6%	90.9%	57.8%	12
DCLK1	23.2%	90.9%	57.0%	15
SULT2B1	18.8%	94.5%	56.7%	17
C14orf37	18.8%	94.5%	56.7%	18
MAGEA8	18.8%	94.5%	56.7%	19
DDX4	13.0%	100.0%	56.5%	20
BCL7A	20.3%	92.7%	56.5%	24
NOL3	21.7%	90.9%	56.3%	26
SSBP4	17.4%	94.5%	56.0%	28
TXNDC2	17.4%	94.5%	56.0%	29
FIGNL2	17.4%	94.5%	56.0%	30
JAKMIP2	18.8%	92.7%	55.8%	34
KCNRG	18.8%	92.7%	55.8%	35
N4BP1	21.7%	89.1%	55.4%	43
ACPP	17.4%	92.7%	55.1%	50
TRIM33	17.4%	92.7%	55.1%	51
MTERF4	14.5%	94.5%	54.5%	61
TTC1	17.4%	90.9%	54.2%	88
MAGEC2	17.4%	89.1%	53.2%	89